Containing Or Obtained From Capsicum (e.g., Chili Pepper, Cayenne Pepper, Red Pepper, Etc.) Patents (Class 424/760)
-
Patent number: 6932989Abstract: A herbal therapeutic composition is provided which enhances cardiac function comprising hawthorn berry, turmeric root and cayenne pepper. Other herbal substituents which further enhance this novel composition are disclosed including motherwort, bilberry, fresh dandelion root, and ginger root.Type: GrantFiled: August 30, 2003Date of Patent: August 23, 2005Inventor: Artista Marchioni
-
Patent number: 6923977Abstract: A non-toxic animal repellant system which may be used to prevent squirrels from entering residential or commercial buildings using a composition having castor oil, habanero pepper extract and white distilled vinegar. The composition may be sprayed onto surfaces or combined with petroleum jelly and applied to surfaces with a brush.Type: GrantFiled: August 9, 2002Date of Patent: August 2, 2005Inventor: Patricia Boyce
-
Patent number: 6919095Abstract: A method of providing an essential oil extract of capsicum, and the extract itself, are provided. The extract contains capsaicinoid and terpene. Capsicum from which seeds and stems have been removed is mixed, in powder form, with a solvent, especially pentane, to dissolve at least some of the capsicum. During or after the mixing step, the liquid solution of capsicum in the solvent is brought to a temperature of less than or equal to 64° C. to significantly reduce the solvent content thereof and produce an essential oil extract that contains capsaicinoid and terpene, especially in the naturally occurring ratio thereof.Type: GrantFiled: September 20, 2002Date of Patent: July 19, 2005Assignee: New Mexico Tech Research FoundationInventor: Lorenzo Torres
-
Publication number: 20040224037Abstract: This method of medical treatment claims a use of Capsaicin (8-methyl-n-vanillyl-6-nonenamide), its derivatives, vanilloids and capsicum extract, to combat and control HIV (humans immunodeficiency virus) and aids (acquired immunodeficiency syndrome). An evaluation of a capsicum sp consumption of a long term aids survivors group permitted a definition of more efficacious ways to administer the substance. capsaicin intravenous and by subcutaneous or intramuscular administration at low concentration implemented by using infuses, it inhibits HIV replication and stimulates the production and proliferation of lymphocytes and cells nk. Also it acts as desinfectant in macrophages, and has a power as anticancer and antioxidant agent. Moreover has the property to control and annihilate common oportunistic illnesses related to HIV due to its triple antibiotic characteristics.Type: ApplicationFiled: March 22, 2004Publication date: November 11, 2004Inventor: Gonzalo Romero-Matos
-
Publication number: 20040202735Abstract: Methods and kits for controlling bleeding from a disrupted blood vessel, wherein a vanilloid receptor agonist is administered to the site of the disruption of the blood vessel in a quantity sufficient to control the bleeding.Type: ApplicationFiled: April 8, 2003Publication date: October 14, 2004Inventors: Bob M. Moore, Duane D. Miller
-
Publication number: 20040191338Abstract: Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a tricyclic antidepressant.Type: ApplicationFiled: December 18, 2003Publication date: September 30, 2004Applicant: AlgoRxInventors: Ronald M. Burch, Richard B. Carter, Jeff Lazar
-
Publication number: 20040185126Abstract: The present invention comprises a pain balm comprising a fermentation extract of the cultivar of the genus capsicum.Type: ApplicationFiled: March 10, 2004Publication date: September 23, 2004Inventor: Jerry V. Mayeux
-
Publication number: 20040186182Abstract: Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a non-anesthetic sodium channel blocker.Type: ApplicationFiled: December 18, 2003Publication date: September 23, 2004Applicant: AlgoRxInventors: Ronald M. Burch, Richard B. Carter, Jeff Lazar
-
Patent number: 6780444Abstract: The invention concerns cosmetic and/or pharmaceutical and/or dermatological compositions and methods for preparing them. The composition is characterized in that it comprises a mixture called base mixture, consisting of a liquid extracted from a mixture (M) of tomatoes and apples once the spontaneous chemical reaction initiated by the mixture of the two crushed plants is completed. The invention is applicable to skin care.Type: GrantFiled: August 23, 1999Date of Patent: August 24, 2004Inventor: Alma Reza
-
Publication number: 20040161481Abstract: Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering an effective amount of a NSAID to decrease an undesired effect of the capsaicinoid.Type: ApplicationFiled: December 18, 2003Publication date: August 19, 2004Applicant: AlgoRxInventors: Ronald M. Burch, Richard B. Carter, Jeff Lazar
-
Publication number: 20040156931Abstract: Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a vasodilator.Type: ApplicationFiled: December 18, 2003Publication date: August 12, 2004Applicant: AlgoRxInventors: Ronald M. Burch, Richard B. Carter, Jeff Lazar
-
Publication number: 20040151780Abstract: A dry, powder, animal repellent that does not harm animals or plants. The repellant uses dried and powdered blood meal mixed with chili powder. The repellant is mixed together in a large container and then sprinkled around or into the soil around plants or into a tunnel opening formed by a rodent. In the first embodiment, designed to repel dogs and cats, the composition contains a 60%/40% (w/w) mixture of blood meal and chili powder, respectively. In the second embodiment, the concentration of blood meal to chile powder is is increased (89%/11%) to promote greater plant growth and for greater absorption into the worm and grub living in the soil.Type: ApplicationFiled: January 6, 2004Publication date: August 5, 2004Inventor: John C. Turner
-
Publication number: 20040151790Abstract: The invention relates to an agent for preventing, improving or treating hypertension, which exhibits a hypotensive effect, inhibits the rise of blood pressure and improves hypertension, and food for preventing or improving hypertension, which does not become a burden in daily intake, has a higher antihypertensive effect and is useful as a diet during treatment for patients of hypertension.Type: ApplicationFiled: July 25, 2003Publication date: August 5, 2004Applicant: Kao CorporationInventors: Atsushi Suzuki, Ryuji Ochiai, Ichiro Tokimitsu
-
Publication number: 20040146589Abstract: A method of providing an essential oil extract of capsicum, and the extract itself, are provided. The extract contains capsaicinoid and terpene. Capsicum from which seeds and stems have been removed is mixed, in powder form, with a solvent, especially pentane, to dissolve at least some of the capsicum. During or after the mixing step, the liquid solution of capsicum in the solvent is brought to a temperature of less than or equal to 64° C. to significantly reduce the solvent content thereof and produce an essential oil extract that contains capsaicinoid and terpene, especially in the naturally occurring ratio thereof.Type: ApplicationFiled: September 20, 2002Publication date: July 29, 2004Applicant: New Mexico Tech Research FoundationInventor: Lorenzo Torres
-
Publication number: 20040146590Abstract: The present invention provides methods and kits for the selective ablation of pain-sensing neurons. The methods comprise administration of a vanilloid receptor agonist to a ganglion in an amount that causes death of vanilloid receptor-bearing neurons. Accordingly, the present invention provides methods of controlling pain and inflammatory disorders that involve activation of vanilloid receptor-bearing neurons.Type: ApplicationFiled: March 18, 2004Publication date: July 29, 2004Inventors: Michael J Iadarola, Zoltan Olah, Laszlo Karal
-
Publication number: 20040131707Abstract: A new method is described for the treatment of cancer. In one alternative, the method utilizes two main compositions. The first composition is Soma, a healing herb described in the Rig Veda, the sacred scriptures of the Hindus. The second composition is a composite of plant-derived substances and a mineral. When they are administered to cancer patients following the recommended therapeutic regimen, regression of the cancer results. Alternatively, the second composition can be used alone.Type: ApplicationFiled: September 22, 2003Publication date: July 8, 2004Inventor: Peter Grandics
-
Publication number: 20040126324Abstract: The present invention provides a pharmaceutical that includes, in combination, a resinate and an aversive agent. The resinate includes an ion exchange resin and an drug. The drug is a controlled substance. In variants of the invention, both the aversive agent and the controlled substance are loaded onto the ion exchange resin; the aversive agent is loaded onto the ion exchange resin, and the controlled substance is not loaded onto the ion exchange resin; the controlled substance is loaded onto the ion exchange resin, and the aversive agent is not loaded onto the ion exchange resin; or, the controlled substance is loaded onto a first ion exchange resin, and the aversive agent is loaded onto an ion exchange resin different from the first ion exchange resin.Type: ApplicationFiled: October 6, 2003Publication date: July 1, 2004Inventor: Lyn Hughes
-
Publication number: 20040126430Abstract: The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.Type: ApplicationFiled: September 5, 2003Publication date: July 1, 2004Inventors: Arturo J. Angel, Larry W. Litle, Keith R. Bley, Allan L. Wilcox, Gene Curtis Jamieson, Naweed Muhammad
-
Publication number: 20040109898Abstract: The invention is directed to a topical composition for heightened sensitivity and arousal for humans. The topical composition includes an organic fluid carrier, preferably glycerin, containing an effective amount of capsaicinoids extract, the active principle in chili peppers. In a further embodiment of the invention, the topical composition includes honey and evening primrose oil, in addition to capsaicinoids extract in the glycerin carrier. the present invention also includes a method for heightened sensitivity and arousal for humans. The method includes providing a topical composition, including an organic fluid carrier, preferably glycerin, containing an effective amount of capsaicinoids extract, and applying the topical composition to the genital area of a human to produce heightened sensitivity and arousal.Type: ApplicationFiled: November 26, 2003Publication date: June 10, 2004Inventor: Marilyn V. Zager
-
Publication number: 20040101582Abstract: Methods and compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and methods for administering the compositions to treat various neuropathies.Type: ApplicationFiled: November 25, 2002Publication date: May 27, 2004Inventor: Richard Wolicki
-
Patent number: 6709682Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: GrantFiled: January 8, 2002Date of Patent: March 23, 2004Assignee: In Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 6689399Abstract: The present invention provides an anti-inflammatory composition for treatment of joint and muscle pain through transdermnal delivery of a capsacinoid in conjunction with glucosamine. The ingredients of the composition of the present invention, namely, a capsacinoid in combination with a primary amine, such as glucosamine, at a high concentration, interact in a synergistic manner to provide a prolonged effect of pain relief when used in the treatment of joint and/or muscle pain associated with an inflammatory response. The prolonged pain relief effect is achieved without incurring the intense burning or stinging sensation usually associated with topical capsaicin administration. The present invention also provides methods for relieving joint and/or muscle pain associated with an inflammatory response, which employ the composition of the present invention.Type: GrantFiled: March 16, 2000Date of Patent: February 10, 2004Inventor: James R. Dickson
-
Publication number: 20040018987Abstract: The invention provides methods and compositions for treatment of tumors comprising administering to subject bearing a tumor an effective amount of at least one agent that decreases the [GSH]2/[GSSG] ratio in the malignant cells of said tumor, wherein said at least one agent is administered continuously to said patient for a period of time within the range of from about 15 to about 75 hours.Type: ApplicationFiled: July 18, 2003Publication date: January 29, 2004Inventors: Arnold Hoffman, Lee M. Spetner, Michael Burke
-
Publication number: 20030224064Abstract: The present invention relates to a composition for the treatment of acne comprising chlorine dioxide or chlorine dioxide generating compounds as acne reduction agents. The invention also relates to a method for treating acne by topically administering one of the compositions in an amount therapeutically effective to reduce the redness and blemishes associated with acne.Type: ApplicationFiled: April 24, 2003Publication date: December 4, 2003Inventor: William O. Kling
-
Publication number: 20030224029Abstract: Disclosed are compositions and methods for repelling insects. The composition is formulated as an aqueous solution to be sprayed on a surface from which insects are to be repelled. In preferred embodiments, the composition is a non-toxic and biodegradable insect repellent comprising an aqueous carrier, at least about 0.05 percent by volume of hot pepper extract, at least about 0.05 percent by volume of garlic extract, and at least about 0.05 percent by volume of Neem seed oil.Type: ApplicationFiled: May 31, 2002Publication date: December 4, 2003Applicant: Holy Terra Products, Inc.Inventor: James F. White
-
Publication number: 20030215532Abstract: The present invention is directed to a sensate composition including at least one cooling sensate, warming sensate and tingling sensate. The tingling sensate is at least one of Jambu Oleoresin and Spilanthol. The present invention is further directed to a method of using the sensate composition in a food, pharmaceutical or personal care product.Type: ApplicationFiled: June 17, 2003Publication date: November 20, 2003Applicant: Takasago International CorporationInventors: Tetsuo Nakatsu, Peter J. Mazeiko, Andrew T. Lupo, Carter B. Green, Charles H. Manley, David J. Spence, Hideaki Ohta
-
Publication number: 20030203060Abstract: A medicine that is topically applied comprises vegetable or fruit matter, including materials resulting from extracts of fruit or vegetable juices, and including juices have undergone a fermentation process. These ingredients are combined and processed by a device that applies a current through a metallic electrode, which contributes metal to the medicine. In another process, the device may be used to remove alloys from metals. Alloys may be removed from gold, such as gold jewelry, and from other metals such as copper.Type: ApplicationFiled: May 30, 2003Publication date: October 30, 2003Inventor: Joe Ajrulahi
-
Patent number: 6620440Abstract: The present invention relates to the use of nutritional supplement compositions to overcome nutritional deficiencies typically associated with the normal mammalian diet. The compositions of the present invention are obtained by combining fish oil, garlic powder, rutin, capsaicin, vitamin A, vitamin C, vitamin E, selenium, and one or more juice concentrates.Type: GrantFiled: June 30, 2000Date of Patent: September 16, 2003Assignee: Viva America Marketing, Inc.Inventors: Houn Simon Hsia, David Fan
-
Publication number: 20030170181Abstract: A method is provided for treating a patient with a methylphenidate-responsive condition that is at a risk of abusing or becoming addicted to methylphenidate. The patient is first evaluated for an elevated risk of drug abuse or addiction through psychological evaluations and then treated with a methylphenidate product that includes an emesis-inducing agent that is inert when ingested orally and only produces emesis when snorted or taken intravenously or a topical analgesic that is inert when ingested orally and only produces irritation when snorted or taken intravenously. The method includes delivering the methylphenidate in a pulsatile delivery system such that the emesis-inducing agent or the topical analgesic is included in one of the pulsatile dosages.Type: ApplicationFiled: December 16, 2002Publication date: September 11, 2003Inventor: Kamal K. Midha
-
Publication number: 20030143291Abstract: Herbal compositions and methods suitable for weight loss management and for treating diabetes are disclosed. The compositions comprise Ferula hermonis or an extract thereof, or Ferula hermonis with selected herbs, extracts thereof, and mixture thereof. The methods of reducing weight, and treating diabetes in patients involve oral administration of the compositions. The invention further relates to a method of extracting and standardizing Ferula hermonis extracts and tincture useful for human health.Type: ApplicationFiled: January 31, 2002Publication date: July 31, 2003Inventor: Yousry M.A. Naguib
-
Publication number: 20030133951Abstract: Pharmaceutical compositions are disclosed for the treatment of acute, chronic and/or neuropathic pain. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an analgesic agent and a pharmaceutically acceptable carrier. The analgesic agent is selected from opioid analgesics, NMDA antagonists, substance P antagonists, COX 1 and COX 2 inhibitors, tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), capsaicin receptor agonists, anesthetic agents, benzodiazepines, skeletal muscle relaxants, migraine therapeutic agents, anti-convulsants, anti-hypertensives, anti-arrythmics, antihistamines, steroids, caffeine, and botulinum toxin. The method of using these compounds and a method of treating acute, chronic and/or neuropathic pain and migraine in a mammal including a human is also disclosed.Type: ApplicationFiled: January 21, 2003Publication date: July 17, 2003Applicant: Pfizer Inc.Inventors: Jotham W. Coe, Steven B. Sands, Edmund P. Harrigan, Brian T. O'Neill, Eric J. Watsky
-
Publication number: 20030125347Abstract: A pharmaceutical composition and an oral dosage form are disclosed comprising an opiate and an irritant. A method is also described for discouraging abuse of an opiate comprising combining a therapeutically effective amount of an opiate and an irritant into an oral dosage form. A method is also described for treating pain by administering a therapeutically effective amount of an opiate and an irritant in an oral dosage form.Type: ApplicationFiled: November 4, 2002Publication date: July 3, 2003Applicant: Elan Corporation plcInventors: Kirsten A. Anderson, James M. Hoch, Gary Liversidge, Jean Marie Duvall, Joshua R. Slavitt
-
Patent number: 6586018Abstract: An herbal composition is disclosed and claimed. One of the compositions disclosed includes the combination of sage leaf, red raspberry leaf, bayberry bark, capsicum pepper, damiana leaf, ginger root, licorice root, vaierian root, black cohosh root, red clover extract and kudzu root. Other compositions of the herbs are disclosed and claimed. The composition is bound in tablet form and administered orally. Alternatively, the composition is applied to the skin of the user as a cream, a patch or spray.Type: GrantFiled: August 31, 2001Date of Patent: July 1, 2003Inventor: Sabina Fasano
-
Publication number: 20030108597Abstract: The present invention relates to compositions and methods for the administration of lipid-based vehicles to treat various disorders, including bladder inflammation, infection, dysfunction, and cancer. In various aspects, the compositions and methods of the invention are useful for prolonged delivery of drugs, e.g., antibiotics, pain treatments, and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system, and other organs or body systems. In particular, the present invention relates to liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin, and toxins, such as botulinum toxin, for the treatment of bladder conditions, including pain, inflammation, incontinence, and voiding dysfunction. Further related are methods of using these vehicles alone or in conjunction with antibodies, e.g., uroplakin antibodies, to improve duration of liposome attachment, and provide a long-term intravesical drug delivery platform.Type: ApplicationFiled: August 13, 2002Publication date: June 12, 2003Inventors: Michael B. Chancellor, Matthew O. Fraser, Yao-Chi Chuang, William C. de Groat, Leaf Huang, Naoki Yoshimura
-
Publication number: 20030105159Abstract: This invention relates to kavalactone-containing compositions, and more particularly to compositions having compounds derived from kavalactones and from capsaicinoids. The compositions are useful in modulating pain, and thus can be used to mediate, or eliminate, sensations of pain, thereby providing pain relief and reduction.Type: ApplicationFiled: August 8, 2002Publication date: June 5, 2003Inventors: Joel McCleary, Peter S. Staats
-
Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases
Publication number: 20030104082Abstract: An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the prescribed time. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent and a nutrient. In the preferred form, the medicine comprises: Echinacea and Commiphora myrrha phytochemicals, benzalkonium chloride, a sterile water solution, and folic acid.Type: ApplicationFiled: February 26, 2002Publication date: June 5, 2003Inventor: Meryl J. Squires -
Publication number: 20030104085Abstract: The present invention provides methods and kits for treating back pain, especially chronic back pain. The methods comprise administering a vanilloid receptor agonist, preferably a capsaicin.Type: ApplicationFiled: December 5, 2001Publication date: June 5, 2003Inventor: David C. Yeomans
-
Publication number: 20030082249Abstract: A composition for use in treating or preventing mucositis, and/or xerostomia, including capsaicin or capsaicin derivative, and one or more additional compounds useful in treating mucositis and/or xerostomia, wherein the composition is provided in an oral delivery vehicle. The invention also relates to a method of treating or preventing mucositis and/or xerostomia, and a method for preparing such a composition.Type: ApplicationFiled: October 26, 2001Publication date: May 1, 2003Applicant: Ovation PharmaceuticalsInventor: Gary Gordon
-
Publication number: 20030072821Abstract: The invention described herein encompasses methods and compositions of preventing or treating cancer comprising the administration of a combination of catechins and vanilloids. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). In a preferred embodiment the catechins have been treated with tannase. Compositions of vanilloids include, but are not limited to vanillylamine, the head group of capsaicin. The unique compositions of the invention contain various combinations of the catechins and vanilloids, in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses various modes of administration of the therapeutic compounds, including formulations which may be used as a dietary or nutritional supplement or as a therapeutic compound.Type: ApplicationFiled: February 22, 2002Publication date: April 17, 2003Inventors: Dorothy M. Morre, D. James Morre
-
Publication number: 20030068392Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.Type: ApplicationFiled: August 6, 2002Publication date: April 10, 2003Inventor: Richard Sackler
-
Publication number: 20030068371Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid.Type: ApplicationFiled: August 6, 2002Publication date: April 10, 2003Inventors: Benjamin Oshlack, Curtis Wright, Christopher Breder
-
Publication number: 20030068370Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.Type: ApplicationFiled: August 6, 2002Publication date: April 10, 2003Inventor: Richard Sackler
-
Publication number: 20030068276Abstract: Solid oral dosage forms of controlled substances containing aversive agents are useful in reducing abuse by chewing or inhaling.Type: ApplicationFiled: November 2, 2001Publication date: April 10, 2003Inventors: Lyn Hughes, Simon Andrew Bellamy
-
Publication number: 20030064122Abstract: A pharmaceutical composition intended for oral use contains the effective ingredient(s), capsaicin, and other typical fillers and excipients. The composition is preferably in the form of a solid oral dosage form. Transdermally administered compositions are also within the purview of the invention. Aside from the effective pharmaceutical ingredient(s) the composition includes an amount of capsaicin which serves as a deterrent to the intranasal, intravenous, or oral abuse of the composition. Such a composition deters abusers from crushing prescription pharmaceutical tablets for abusive snorting, injection, or ingestion.Type: ApplicationFiled: April 8, 2002Publication date: April 3, 2003Applicant: Endo Pharmaceuticals, Inc.Inventors: Michael Goldberg, Bradley Stuart Galer, Huai-Hung Kao
-
Publication number: 20030059478Abstract: A new method is described for the treatment of cancer. The method utilizes two main parts. The first part is Soma, a healing herb described in the Rig Veda, the sacred scriptures of the Hindus. The second part is a composite of plant-derived substances and a mineral. When they are administered to cancer patients following the recommended therapeutic regimen, regression of the cancer results.Type: ApplicationFiled: August 23, 2002Publication date: March 27, 2003Inventor: Peter Grandics
-
Patent number: 6534078Abstract: A micro-encapsulated pepper-mustard composition which comprises positioning pepper and mustard mixtures within a cluster of surfactant molecules, i.e. micelles, dispersed in water. This micro-encapsulation process involves first forming the micelles in water by exceeding the given critical micelle concentration for either one, two, or three different surfactant types. The active ingredient, pepper and mustard, is then added to this mixture and subsequently emulsified into small liquid drops in order to facilitate swelling of the micelles by way of migration or diffusion of the active ingredient molecules through the water phase and into the micelles. The resulting encapsulated pepper and mustard is effectively stabilized by the surfactant molecules, and the resulting stabilized micro-encapsulated dispersion will not undergo phase separation.Type: GrantFiled: October 18, 1999Date of Patent: March 18, 2003Assignee: Natural Pest FX, Inc.Inventors: Thomas M. Strzemiemski, Fortunato J. Micale
-
Publication number: 20030049272Abstract: A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a central nervous system stimulant selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a mucous membrane irritant selected from the group consisting of organic and inorganic acid, salt, ketone, nitrite, sulfide, bisulfate, persulfate, glycerophosphate, hypophosphate, borate, titanate, amino acid, peptide, and combinations thereof, wherein the mucous membrane irritant produces irritation when contacted with the skin or mucous membrane.Type: ApplicationFiled: August 30, 2001Publication date: March 13, 2003Inventors: Yatindra Joshi, Russell Somma
-
Publication number: 20030017527Abstract: This invention relates to human vanilloid receptor-like protein 2 (VRL-2) polypeptides, polynucleotides encoding such polypeptides, polynucleotide probes or primers, expression vectors and host cells comprising such DNA molecules. This invention further relates to a process for producing the polypeptides; an antibody immunospecific for the polypeptide; a diagnostic kit for diagnosing the VRL-2 receptor related disease; a method for screening to identify modulators which modulate the polypeptides; modulators identified by the screening method; a pharmaceutical composition for treatment of conditions associated with biological function of the polypeptides; and a non-human transgenic animal model for vanilloid receptor-like gene. The polypeptides and the DNA molecules of the present invention can be used to identify agonists, antagonists or the like.Type: ApplicationFiled: May 30, 2001Publication date: January 23, 2003Inventors: Katsuhiro Shinjo, Hikaru Yabuuchi
-
Publication number: 20030003123Abstract: Cosmetic/dermatological compositions suited for combating the adverse signs of cutaneous skin aging, notably for maintaining and/or enhancing the thickness of the skin, particularly the thickness of the epidermis, comprise a thus-effective amount of at least one substance/species which is active with respect to the trophicity of the cutaneous nerves and/or at least one neurostimulant and/or at least one neuroactivator and/or at least one neuromediator, formulated into a cosmetically/dermatologically acceptable vehicle, diluent or carrier therefor.Type: ApplicationFiled: May 29, 2002Publication date: January 2, 2003Inventors: Olivier de Lacharriere, Stephanie Nouveau
-
Publication number: 20020192308Abstract: An appetite suppressant and a method for controlling the weight of a person is described. The appetite suppressant is a composition that includes a chromium additive, green tea, and green tea leaf extract containing catechin polyphenols. The method for controlling the weight of a person includes replacing at least one meal per day with a soy meal replacement and taking an appetite suppressant that contains a chromium additive, green tea, and green tea leaf extract. Also described is a weight control kit that includes a soy meal replacement and an appetite suppressant that contains a chromium additive, green tea, and green tea leaf extract.Type: ApplicationFiled: June 14, 2001Publication date: December 19, 2002Inventor: John Mamana